pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$TRAWTraws Pharma, Inc.

$TRAW
Newtown, PA, USupdated 2mo ago
SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
4
marketed
2
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(4)

pipeline depth4 products
Phase 2: 1Marketed: 2Unknown: 1
1Phase 22Marketed1Unknown
Marketed
DYANAVEL XR 20
attention deficit hyperactivity disorder
Sodium-dependent dopamine transporterSodium-dependent noradrenaline transporter
Marketed
TUZISTRA XR
Histamine H1 receptor
Phase 2
rigosertib sodium
Non-Small Cell Lung Cancer
drug
DYANAVEL XR
1 INDICATIONS AND USAGE DYANAVEL XR is indicated for the…
Sodium-dependent dopamine transporterSodium-dependent noradrenaline transporter

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase1Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteersrecruitingn=24
  • phase2Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Modelnot yet recruitingn=165
  • phase2This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenzaactive not recruitingn=105
  • phase1Evaluation Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of 83-0060 in Healthy Volunteerscompletedn=57
  • phase1A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteerscompletedn=66
  • phase2Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19recruitingn=90
  • phase2Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignanciesunknownn=60
  • phase1Study of ON 123300 in Patients With Advanced Cancerunknownn=36
more trials →

Insider activity

source: SEC Form 4
routine RSU / option mechanics (6)
  • Mar 8, 26grantParker Charles Nolan · Chief Financial Officer104,544 sh
  • Mar 8, 26grantClarke Trafford · 33,435 sh
  • Mar 8, 26grantCAUTREELS WERNER · 31,258 sh
  • Mar 8, 26grantLeaman John Harold · 33,435 sh
  • Mar 8, 26grantDukes Iain D. · Chief Executive Officer231,336 sh
  • Mar 8, 26grantPauza Charles David · Chief Science Officer Virology118,367 sh
🐶 Hiring Signal
No open roles indexed yet — view Traws Pharma, Inc. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$TRAW
SEC CIK
0001130598
country
US
source
sec_tickers
top tags
NSCLC1Oncology1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 3m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?